Question 11

Varenicline is indicated for smoking cessation.

Varenicline is primarily used as a medication to assist individuals in quitting smoking. It works by targeting nicotine receptors in the brain, helping to reduce cravings and withdrawal symptoms associated with smoking cessation.

A) smoking cessation

This option is correct as varenicline is specifically designed and approved for aiding in smoking cessation. It helps to decrease the pleasure associated with smoking and reduces withdrawal symptoms, making it effective for those looking to quit.

B) ulcerative colitis

This option is incorrect. Varenicline is not indicated for treating ulcerative colitis, which is an inflammatory bowel disease requiring different therapeutic approaches. Medications for ulcerative colitis typically include aminosalicylates, corticosteroids, and immunosuppressants.

C) seasonal affective disorder

This option is incorrect. Varenicline is not used to treat seasonal affective disorder, a type of depression that occurs at a specific time of year. Treatments for this condition usually involve light therapy, psychotherapy, and antidepressant medications.

D) somnambulism

This option is also incorrect. Varenicline does not have an indication for somnambulism, or sleepwalking, which is a sleep disorder. Treatment for somnambulism may involve addressing underlying sleep disturbances and may include behavioral strategies or medications specifically targeted for sleep disorders.

Conclusion

Varenicline is definitively indicated for smoking cessation, as it directly targets the neurological pathways involved in nicotine addiction. All other options fail to align with the therapeutic use of varenicline, as they pertain to entirely different medical conditions that require distinct treatment modalities.